右美托咪定作为罗哌卡因腘窝坐骨神经阻滞辅助剂用于小儿足部手术的随机双盲安慰剂对照试验
本研究为平行双盲随机对照试验,纳入90例2-5岁、体重>5 kg在脊髓麻醉下接受足踝手术的患儿,随机分为三组:0.5%罗哌卡因加生理盐水(对照)、加右美托咪定0.1 mg/kg(DEX0.1)或0.05 mg/kg(DEX0.05)。主要结局为首次补救阿片类药物镇痛时间,DEX0.1组显著长于DEX0.05组和对照组。结论:神经周围右美托咪定显著延长术后运动阻滞时间,未影响血糖、NLR或PLR水平。
要点
- DEX0.1组首次补救阿片镇痛时间较DEX0.05组和对照组显著延长。
- DEX0.1组运动阻滞时间显著长于DEX0.05组和对照组。
- DEX0.1组总阿片消耗量显著低于对照组。
核心结论
- 神经周围右美托咪定显著延长术后运动阻滞时间,未影响血糖、NLR或PLR水平。
研究设计与样本
- 平行双盲随机对照试验,纳入90例2-5岁、体重>5 kg在脊髓麻醉下接受足踝手术的患儿。
- 随机分为三组:0.5%罗哌卡因加生理盐水(对照)、加右美托咪定0.1 mg/kg(DEX0.1)或0.05 mg/kg(DEX0.05)。
- 主要结局为首次补救阿片类药物镇痛时间。
主要发现
- 首次补救阿片镇痛时间DEX0.1组为18.4小时(SD 2.6),DEX0.05组为16小时(SD 2.8),平均差2.2小时(95%CI 0.7至3.6),p<0.01。
- 首次补救阿片镇痛时间DEX0.1组与对照组8.5小时(SD 1.5)相比,平均差-9.9(95%CI -11.4至-8.4),p<0.001。
- 运动阻滞时间DEX0.1组17.3小时(SD 2.5),DEX0.05组15.2小时(SD 2.7),p<0.01;对照组7.8±1.1小时,p<0.001。
- DEX0.1组总阿片消耗量显著低于对照组(p=0.01)。
- NLR、PLR和血糖水平在基线、术后24小时和48小时组间无显著差异。
临床怎么用
- 小儿足踝手术中,0.5%罗哌卡因联合右美托咪定0.1 mg/kg可延长镇痛和运动阻滞时间并减少阿片消耗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study assessed the effect of perineural dexamethasone on block duration, opioid requirement, blood glucose levels, and stress response to surgery as measured by the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), following pediatric foot and ankle surgery. METHODS: In this parallel, double-blinded randomized controlled trial, 90 children (ages 2-5 years, >5 kg) scheduled for foot or ankle surgery under spinal anesthesia with ultrasound-guided single-shot popliteal sciatic nerve block were randomized into 3 groups: 0.5% ropivacaine with saline (control), 0.5% ropivacaine plus dexamethasone 0.1 mg/kg (DEX0.1), and 0.5% ropivacaine plus dexamethasone 0.05 mg/kg (DEX0.05). Primary outcome was the time to first rescue opioid analgesia. Secondary outcomes included motor block duration, pain scores, NLR, PLR, and blood glucose levels. RESULTS: Time to first rescue opioid analgesia was significantly longer in the DEX0.1 group compared with the DEX0.05 group (18.4 hours, SD 2.6 hours vs 16 hours, SD 2.8 hours), with a mean difference of 2.2 hours (95% CI 0.7 to 3.6), p<0.01; and the control group (8.5 hours, SD 1.5 hours), with a mean difference of -9.9 (95% CI -11.4 to -8.4), p<0.001. Motor block was significantly longer in the DEX0.1 group (17.3 hours, SD 2.5 hours) compared with the DEX0.05 (15.2 hours, SD 2.7 hours; p<0.01) and control groups (7.8±1.1, p<0.001). Total opioid consumption was significantly lower in the DEX0.1 group compared with the control group (p=0.01). NLR, PLR, and glucose levels did not differ significantly between the groups at baseline, 24 hours, and 48 hours post surgery. CONCLUSIONS: Perineural dexamethasone significantly prolonged postoperative motor block duration and did not influence blood glucose, NLR, or PLR levels. TRIAL REGISTRATION NUMBER: NCT06086418.
引用
- Reysner M, Reysner T, Janusz P, et al. Dexamethasone as a perineural adjuvant to a ropivacaine popliteal sciatic nerve block for pediatric foot surgery: a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2025. PMID: 39209730. doi:10.1136/rapm-2024-105694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。